NCT00411424View on ClinicalTrials.gov

Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

ASK8007

IV

DRUG

Placebo

IV

Trial Locations (10)

1027

Budapest

3000

Leuven

Unknown

Dublin

Amsterdam

Groningen

A Coruña

Barcelona

Santiago

London

Newcastle

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY